Stocks Overview

LAST PRICE
30.3200
TODAY'S CHANGE (%)
Trending Down-0.9800 (-3.1310%)

Bid / Lots
30.3500/ 181
Ask / Lots
30.7000/ 5
Open / Previous Close
31.7900 / 31.3000
Day Range
Low 29.6300
High 32.3000
52 Week Range
Low 8.7900
High 42.2000
Volume
1,981,598
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Tuesday's close: 31.3
Time	Volume	SAVA
09:32 ET	26891	31.3201
09:34 ET	9705	31.9
09:36 ET	26652	31.75
09:38 ET	16732	31.8199
09:39 ET	23299	31.6567
09:41 ET	39934	31.115
09:43 ET	10884	31.265
09:45 ET	5000	31.19
09:48 ET	41497	30.94
09:50 ET	10460	31.015
09:52 ET	5822	31.065
09:54 ET	5750	31.16
09:56 ET	5775	31.36
09:57 ET	15862	30.7617
09:59 ET	18424	30.58
10:01 ET	39642	30.35
10:03 ET	8899	30.48
10:06 ET	7878	30.431
10:08 ET	6473	30.4
10:10 ET	19877	30.6804
10:12 ET	23322	30.9399
10:14 ET	40413	31.36
10:15 ET	10495	31.18
10:17 ET	13667	31.58
10:19 ET	20099	31.57
10:21 ET	7014	31.37
10:24 ET	3794	31.3
10:26 ET	1450	31.425
10:28 ET	4864	31.63
10:30 ET	3760	31.741
10:32 ET	11119	31.25
10:33 ET	6153	31.31
10:35 ET	7490	31.305
10:37 ET	1201	31.41
10:39 ET	7432	31.39
10:42 ET	1185	31.435
10:44 ET	9859	31.05
10:46 ET	1225	31.3
10:48 ET	35836	30.85
10:50 ET	16936	30.57
10:51 ET	9942	30.4
10:53 ET	9116	30.4
10:55 ET	17964	30.16
10:57 ET	37218	29.92
11:00 ET	14131	30.27
11:02 ET	3042	30.3181
11:04 ET	3926	30.31
11:06 ET	1579	30.341
11:08 ET	6637	30.43
11:09 ET	1890	30.33
11:11 ET	500	30.525
11:13 ET	3387	30.61
11:15 ET	3583	30.5
11:18 ET	969	30.5
11:20 ET	859	30.35
11:22 ET	545	30.39
11:24 ET	500	30.31
11:26 ET	1000	30.335
11:27 ET	2326	30.33
11:29 ET	9100	30.2898
11:31 ET	4952	30.4137
11:33 ET	875	30.45
11:36 ET	11850	30.37
11:38 ET	678	30.425
11:40 ET	2819	30.455
11:42 ET	2850	30.28
11:44 ET	9378	30.23
11:45 ET	1239	30.12
11:47 ET	1050	30.095
11:49 ET	5001	30.12
11:51 ET	100	30.12
11:54 ET	1130	30.13
11:56 ET	1708	30.25
11:58 ET	442	30.1883
12:00 ET	2850	30.0891
12:02 ET	11920	29.9039
12:03 ET	5300	30.0543
12:05 ET	1711	30.04
12:07 ET	936	30.21
12:09 ET	300	30.2496
12:12 ET	4047	30.17
12:14 ET	7895	30.2
12:16 ET	8861	30.03
12:18 ET	4393	29.9207
12:20 ET	18958	29.9299
12:21 ET	1500	30
12:23 ET	11211	30.16
12:25 ET	14800	30.185
12:27 ET	4672	30.35
12:30 ET	2034	30.22
12:32 ET	100	30.116
12:34 ET	3217	30.3
12:36 ET	3191	30.39
12:38 ET	3456	30.37
12:39 ET	962	30.395
12:41 ET	1102	30.345
12:43 ET	1204	30.37
12:45 ET	1480	30.35
12:48 ET	2003	30.46
12:50 ET	1774	30.406
12:52 ET	2411	30.41
12:54 ET	100	30.39
12:56 ET	593	30.4525
12:57 ET	600	30.55
12:59 ET	1772	30.53
01:01 ET	500	30.5172
01:03 ET	1124	30.5338
01:06 ET	718	30.44
01:08 ET	900	30.51
01:12 ET	1100	30.46
01:14 ET	2548	30.5
01:15 ET	3072	30.54
01:17 ET	1851	30.4418
01:21 ET	762	30.2979
01:24 ET	2634	30.1999
01:26 ET	3008	30.0675
01:30 ET	2672	30.3
01:32 ET	170	30.26
01:33 ET	1321	30.383
01:37 ET	3508	30.39
01:39 ET	200	30.4101
01:42 ET	305	30.3849
01:44 ET	1422	30.34
01:48 ET	800	30.42
01:50 ET	457	30.395
01:51 ET	900	30.405
01:53 ET	3000	30.55
01:55 ET	6304	30.51
01:57 ET	2600	30.68
02:00 ET	5985	30.795
02:02 ET	10618	31.21
02:04 ET	30472	31.49
02:06 ET	21177	31.1
02:08 ET	13553	30.9723
02:09 ET	14903	30.765
02:11 ET	7669	30.715
02:13 ET	14286	30.56
02:15 ET	3050	30.51
02:18 ET	23121	30.69
02:20 ET	5200	30.8
02:22 ET	9300	31.0695
02:24 ET	3902	30.985
02:26 ET	7346	31.1304
02:27 ET	850	31.27
02:29 ET	2870	31.3271
02:31 ET	5339	31.5486
02:33 ET	9321	31.5
02:36 ET	7418	31.68
02:38 ET	9259	31.58
02:40 ET	5940	31.85
02:42 ET	26879	32.1
02:44 ET	21924	31.8098
02:45 ET	6106	31.49
02:47 ET	15473	31.74
02:49 ET	4247	31.37
02:51 ET	2547	31.465
02:54 ET	4253	31.54
02:56 ET	1722	31.595
02:58 ET	1840	31.59
03:00 ET	7232	31.33
03:02 ET	13177	31.26
03:03 ET	33771	30.62
03:05 ET	8473	30.6504
03:07 ET	9868	30.43
03:09 ET	2200	30.67
03:12 ET	900	30.674
03:14 ET	6786	30.89
03:16 ET	10874	30.88
03:18 ET	3415	30.73
03:20 ET	2163	30.68
03:21 ET	7489	30.52
03:23 ET	6041	30.58
03:25 ET	1204	30.72
03:27 ET	1666	30.85
03:30 ET	2500	31.025
03:32 ET	1214	30.76
03:34 ET	2387	30.8119
03:36 ET	5673	30.68
03:38 ET	2206	30.525
03:39 ET	1649	30.645
03:41 ET	4492	30.51
03:43 ET	1938	30.495
03:45 ET	13943	30.43
03:48 ET	5279	30.45
03:50 ET	3925	30.45
03:52 ET	4904	30.42
03:54 ET	5526	30.415
03:56 ET	8699	30.4995
03:57 ET	32573	30.32
03:59 ET	81395	30.32

Data delayed at least 15 minutes.

Sep 9, 2024
- DJ Cassava Sciences' Executive Chairman Rick Barry Becomes CEO, from 9:06AM ET on Monday Sep 09, 2024 by Dow Jones
  9:06AM ET on Monday Sep 09, 2024 by Dow Jones
- Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
  8:30AM ET on Monday Sep 09, 2024 by Dow Jones
- Press Release: Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
  8:30AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 3, 2024
- Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference, from 8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
  8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesSAVA Cassava Sciences Inc	1.5B	-74.8x	---
United StatesBLTE Belite Bio Inc	1.5B	-39.4x	---
United StatesSNDX Syndax Pharmaceuticals Inc	1.5B	-5.3x	---
United StatesKURA Kura Oncology Inc	1.5B	-9.1x	---
United StatesSYRE Spyre Therapeutics Inc	1.4B	-1.9x	---
United StatesIRON Disc Medicine Inc	1.4B	-13.0x	---
As of 2024-09-19

Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.

Contact Information

Headquarters: 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300AUSTIN, TX, United States 78731
Phone: 512-501-2444
Fax: 512-614-0414

Executives

Non-Executive Independent Chairman of the Board: Claude Nicaise
Chief Executive Officer: Richard Barry
Chief Financial Officer: Eric Schoen
Senior Vice President, General Counsel: R. Christopher Cook
Chief Medical Officer: James Kupiec

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$1.5B
Revenue (TTM)	$0.00
Shares Outstanding	48.0M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	-0.61
EPS	$-0.41
Book Value	$3.25
P/E Ratio	-74.8x
Price/Sales (TTM)	---
Price/Cash Flow (TTM)	---
Operating Margin	---

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Cassava Sciences Inc
NASDAQ:SAVAUnited States

Search Criteria

Charts

Recent News

Sep 9, 2024

DJ Cassava Sciences' Executive Chairman Rick Barry Becomes CEO, from 9:06AM ET on Monday Sep 09, 2024 by Dow Jones

Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones

Press Release: Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones

Sep 3, 2024

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference, from 8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar